HCA Healthcare (HCA) is back in the spotlight as Chief Technology Officer Saikrishna Adivi prepares to speak at the 17th Annual Atlanta C-Level Technology Leadership Summit on August 20, 2026. The appearance is drawing investor attention to the company’s technology agenda.

Recent share price action for HCA Healthcare has been mixed, with the stock up 8.89% on a 1 month share price return yet still down 13.63% on a year to date share price return. The 5 year total shareholder return of 68.77% points to stronger longer term compounding.

If HCA’s tech and digital push has your attention, it can also be useful to compare it with other healthcare related AI opportunities using the 40 healthcare AI stocks

HCA Healthcare is a large, profitable hospital operator with clear growth projects and a busy conference schedule that puts it in front of investors again. After the recent rebound and earlier pullback, do the current numbers still stack up?

Most Popular Narrative: 11.4% Undervalued

The most followed narrative puts HCA Healthcare’s fair value at $458.67 per share compared with the latest close of $406.27, which implies upside if those assumptions hold.

Analysts are assuming HCA Healthcare's revenue will grow by 4.4% annually over the next 3 years. Analysts assume that profit margins will shrink from 8.8% today to 8.2% in 3 years time.

Want to see how HCA Healthcare gets to that higher fair value? The narrative leans on measured revenue growth, steady earnings expansion and a future earnings multiple that still trails the broader healthcare sector.

Result: Fair Value of $458.67 (UNDERVALUED)

However, HCA Healthcare also faces pressure from payer mix shifts and potential changes to Medicaid supplemental payments, which could weigh on margins and challenge this view that the stock is undervalued.

Next Steps

With both risks and rewards in play for HCA Healthcare, this is a moment to move quickly. Review the numbers yourself and pressure test the story against the 3 key rewards and 2 important warning signs.

Looking for more investment ideas beyond HCA Healthcare?

If HCA Healthcare has sharpened your focus, do not stop there. Use screened shortlists to spot fresh opportunities and keep your portfolio ideas flowing.

• Target potential mispricing across the market by reviewing companies highlighted in the 50 high quality undervalued stocks.
• Strengthen your income stream by checking out opportunities inside the 12 dividend fortresses.
• Prioritise resilience first and see which companies pass the quality checks in the 78 resilient stocks with low risk scores.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.